EmailStory Stocks®
Archive
Last Update: 11-Oct-12 11:38 ET
Cantel Medical Down 10% Following Earnings Results
Cantel Medical (CMN) reported fourth quarter earnings of $0.31 per share, excluding a $0.04 tax benefit from the closing of Japan subsidiary, $0.01 worse than the Capital IQ two est avg of $0.32; revenues rose 14.8% year/year to $98.7 mln vs the $99.6 mln two est avg.
"All three business units have greatly benefited from further investments in new product development, sales and marketing programs and the full integration of recent acquisitions for this quarter and for the full year. Most importantly this quarter, gross margins increased by over 6 percentage points to 43.3%, driven by the effective integration of acquisitions, greater sales of higher margin products and improved operating efficiencies... I am optimistic about Cantel's prospects to expand sales and increase profits in fiscal year 2013."
"All three business units have greatly benefited from further investments in new product development, sales and marketing programs and the full integration of recent acquisitions for this quarter and for the full year. Most importantly this quarter, gross margins increased by over 6 percentage points to 43.3%, driven by the effective integration of acquisitions, greater sales of higher margin products and improved operating efficiencies... I am optimistic about Cantel's prospects to expand sales and increase profits in fiscal year 2013."
